Statin Use and In‐Hospital Mortality in Patients With Diabetes Mellitus and COVID‐19
Background Severe coronavirus disease 2019 (COVID‐19) is characterized by a proinflammatory state with high mortality. Statins have anti‐inflammatory effects and may attenuate the severity of COVID‐19. Methods and Results An observational study of all consecutive adult patients with COVID‐19 admitte...
Main Authors: | Omar Saeed, Francesco Castagna, Ilir Agalliu, Xiaonan Xue, Snehal R. Patel, Yogita Rochlani, Rachna Kataria, Sasa Vukelic, Daniel B. Sims, Chikezie Alvarez, Mercedes Rivas‐Lasarte, Mario J. Garcia, Ulrich P. Jorde |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.120.018475 |
Similar Items
-
STATINS AND THE RISK OF DIABETES MELLITUS
by: O. M. Drapkina
Published: (2015-09-01) -
Statins and risk of diabetes mellitus
by: Richard Tjan
Published: (2014-08-01) -
Safety of statins
by: Debasish Maji, et al.
Published: (2013-01-01) -
Statin use and risk of diabetes mellitus
by: Oksana Mikhailovna Drapkina, et al.
Published: (2012-06-01) -
Effects of Statins on Bone
by: Merih Eryavuz Sarıdoğan, et al.
Published: (2003-09-01)